hotspot -WSS

hotspot

author：entertainment 2025-09-30 12:57:32 - browse：27875

Ula Jurkunas, associate director of the cornea service at Mass Eye and Ear, performs the first CALEC surgery. Courtesy Mass Eye and Ear

The first time Phillip Durst saw the big A on the chart, he could hardly believe it. It was the first in a series of letters to check his vision in his left eye. “They keep flipping the chart and it keeps getting smaller and smaller, and I keep identifying the letters — that was huge,” said Durst. “It’s like a miracle.”

A year earlier, in April 2017, Durst had lost sight from that same eye after it was hit by a caustic water treatment solution in a work accident. The damage was so severe that a standard corneal transplant would not resolve it. But in April 2018, he underwent a new, innovative procedure: An eye stem cell transplant led by Ula Jurkunas, the associate director of the cornea service at Mass Eye and Ear in Boston.

Durst, now 51 years old, is the first of four patients who were included in a Phase 1 trial of Cultivated Autologous Limbal Epithelial Cell (CALEC) transplant, the results of which were published Friday in Science Advances. The procedure allowed him to become a suitable candidate for another surgery, the artificial corneal transplant, while rehabilitating his vision — and his life.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： The SUPPORT Act is critical to fighting the opioid crisis

WSS

Popular nasal decongestant doesn't actually relieve congestion

A common UTI test for kids haunts adults as a traumatic 'nightmare'

New Covid vaccine is recommended for everyone 6 months or older

New weight loss drugs vying to be the next Wegovy or Mounjaro

JPM 2024: Verve Therapeutics looks to mainstream genome editing

White House touts steps to stem shortages of cancer treatments

knowledge

hotspot

knowledge

Duchenne breakthrough therapy leaves behind pioneering families

How housing is health care on Long Island

23andMe had bad news about my health. I wish a person had delivered it

Fauci’s Covid grilling leads GOP to weigh foreign research rules

What does generative AI mean for health care? We asked experts

Biotech reporter’s notebook: A sunnier mood at JPM 2024

As demand for Covid shots wanes, Moderna seeks its next success

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Food makers to regulators: Ultra

hotspot

Food makers tried to stack nutrition panel with preferred experts

FDA proposes changes to key medical devices approval pathway

Heart disease and mental health: A look at cardiac psychology

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

How housing is health care on Long Island

Risky weight loss products often used by teens globally, per study

leisure time

leisure time

leisure time

leisure time